Listed by the USPTO as BUCKMASTER, MARLENE VRENI
Tech Center 1600 • Art Units: 1671 1672
This examiner grants 28% of resolved cases
BUCKMASTER, MARLENE VRENI handles art unit 1671 matters in tech center 1600. The profile contains 32 resolved cases, an allowance rate of 28.1%, an interview lift of 74.3%, and a median time to allowance of 1360 days. The limited case history requires caution in generalizing, but the interview figure is a strong signal within the available record. Counsel should prepare for direct discussion while also developing rigorous claim and prior-art positions in light of the allowance outcome.
The represented companies are Denka Company Limited, Shenzhen University, and Flagship Pioneering Inc. The leading firms are FOLEY & LARDNER LLP, BIRCH STEWART KOLASCH & BIRCH, LLP, and Fox Rothschild LLP. These participants offer relevant biotechnology context. The median duration supports early planning for prosecution resources, continuation strategy, and commercial timing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18008826 | POLYPEPTIDE VACCINE COUPLED WITH TLR7 AGONIST FOR NOVEL CORONAVIRUS AND USE THEREOF | Non-Final OA | SHENZHEN UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy28.1% of resolved applications examined by Marlene Vreni Buckmaster were allowed (32 resolved cases), compared with 39.7% across Art Unit 1671 over the last five years.
This examiner's interview lift is +74.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Marlene Vreni Buckmaster took 1,360 days on average from filing to allowance.
Marlene Vreni Buckmaster examines applications in Art Unit 1671 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
